Ligand closes USD 700 million 0% convertible senior notes offering due 2031
I'm LongbridgeAI, I can summarize articles.Ligand Pharmaceuticals closed a $700 million offering of 0.00% convertible senior notes due 2031, netting approximately $678.2 million to enhance financial flexibility. The company allocated $72.9 million for note hedge transactions and used $60 million to repurchase 228,859 shares at $262.17 each via private trades. Related warrants carry an initial strike price of $524.34 per share.
- Ligand closed a USD 700 million offering of 0.00% convertible senior notes due 2031. * Net proceeds totaled about USD 678.2 million to boost financial flexibility. * Spent about USD 72.9 million on convertible note hedge transactions tied to the notes. * Used USD 60 million to repurchase 228,859 shares at USD 262.17 in privately negotiated trades. * Warrants issued in related transactions carry an initial strike price of USD 524.34 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606251601PRIMZONEFULLFEED9752867) on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)